Follow The Filings

THO Thor Industries Inc.

Consumer Discretionary, filed as THOR INDS INC (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2, sold by 1

  • 1 Owner
  • Max 0.2%
  • $492K
  • 1 add

In 2026 Q3 Murphy Pohlad added to Thor Industries.

Who owns this now

Largest portfolio weights among holders, up to 0.2% (Murphy Pohlad, Murphy Pohlad Asset Management). Not free-float ownership.

  1. Murphy Pohlad Add 0.17%

Who owns THO

Sorted by value, long equity only, as of 2026 Q3.

History
Murphy Pohlad, Murphy Pohlad Asset Management 0.17% Add +2.5% 7,127 $492K History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by THO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All THO insider trades
  • $229K bought by 1 insider
  • $703K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Peter Busch Orthwein Director
    Buy
    $229K 2,600 shares at $88.25 +1.9% to stake
    Traded Mar 6 Filed Mar 9
    ↗
  2. W. Todd Woelfer COO
    Sale
    $524K 4,567 shares at $114.85 4.2% of stake
    Traded Jan 15 Filed Jan 16
    ↗
  3. W. Todd Woelfer COO
    Sale
    $178K 1,729 shares at $103.15 1.5% of stake
    Traded Dec 12, 2025 Filed Dec 16, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 21 share withholdings for taxes, 19 stock grants, and 4 gifts.

Congress

No member of Congress reported trading THO in the last three years. 1 member listed it in 2025 annual reports.

All Congress trades

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
8-K 8.01,9.01 Filing Doc
10-K Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue $11.12B $10.04B $9.58B $9.61B
Gross profit $1.6B $1.45B $1.34B $1.21B
Gross margin * 14.4% 14.5% 14.0% 12.6%
Net income $374.27M $265.31M $258.56M $177.54M
Net margin * 3.4% 2.6% 2.7% 1.8%

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $2.79B $2.65B $2.78B $2.74B
Total non-current assets * $4.47B $4.37B $4.29B $4.22B
Total assets $7.26B $7.02B $7.07B $6.96B
Total current liabilities $1.72B $1.57B $1.58B $1.55B
Total non-current liabilities $1.56B $1.38B $1.19B $1.15B
Total equity $3.98B $4.07B $4.29B $4.26B

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations $981.63M $545.55M $577.92M $321.22M
Cash from investing -$222.48M -$146.81M -$64.46M -$125.44M
Cash from financing -$635.68M -$337.68M -$426.31M -$296.62M
Net change in cash $129.68M $60.08M $85.28M -$104.61M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.